The purpose of this CPU Expert Review is to provide clinicians with guidance on the
management of Helicobacter pylori after an initial attempt at eradication therapy fails …

The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known
as statins, are administered as first-line therapy for hypercholesterolemia, both as primary …

The worldwide scenario of antibiotic resistance and the falling number of funds for the
development of novel antibiotics have led research efforts toward the study of specific cost …

Helicobacter pylori infection exhibits a wide disease spectrum ranging from asymptomatic
gastritis, peptic ulcer disease, to gastric cancer. H. pylori can induce dysbiosis of gastric …

Helicobacter pylori (Hp) is a prevalent organism infecting almost half the global population. It
is a significant concern, given its associated risk of gastric cancer, which is the third leading …

Background. Helicobacter pylori (H. pylori), a widespread bacterial pathogen, is associated
with various gastrointestinal diseases, including gastric cancer. Statins, widely prescribed …

Statins could increase the effectiveness of Helicobacter pylori eradication therapies due to
their anti-inflammatory effect. The aim of this study was to analyze the impact of this …

Background: Helicobacter pylori, the most prevalent infection in the world, has great
importance due to being related to peptic ulcer disease, gastric metaplasia, dysplasia, and …

The current big data era has vast amounts of biomedical data that present great interest in
processes related to the search of new drugs. Due to the information available in open …

Helicobacter pylori continues to present therapeutic challenges for clinicians across the
world. This review article aims to consolidate current knowledge of H. pylori infection with a …